CPIX
NASDAQ · Pharmaceuticals
Cumberland Pharmaceuticals
$7.32
-0.23 (-3.05%)
Open$7.54
Previous Close$7.55
Day High$7.55
Day Low$7.03
52W High$8.23
52W Low$1.85
Volume—
Avg Volume138.6K
Market Cap113.42M
P/E Ratio—
EPS$-0.49
SectorPharmaceuticals
Analyst Ratings
Strong Sell
6 analysts
Price Target
+384.3% upside
Current
$7.32
$7.32
Target
$35.45
$35.45
$27.92
$35.45 avg
$53.56
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 46.44M | 45.55M | 7.91M |
| Net Income | -2,957,962 | -2,611,246 | 1.22M |
| Profit Margin | -6.4% | -6.1% | 15.4% |
| EBITDA | 1.41M | 1.32M | 2.16M |
| Free Cash Flow | — | — | 556.1K |
| Rev Growth | +2.0% | +2.0% | +3.2% |
| Debt/Equity | 0.21 | 0.21 | 0.66 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |